Doxorubicin Hydrochloride
- Product NDC
- 0069-4004
- 11-digit product format
- 000694004
- Labeler code
- 0069
- Product ID
- 0069-4004_7de0221b-3903-4ec6-a5ba-9ede8e8a45a6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA050629
- Marketing category
- NDA
- Marketing start
- 2013-03-17
- Marketing end
- 0000-00-00
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0069-4004-05 | Doxorubicin Hydrochloride | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | | 14 |
| 0069-4004-05 | Doxorubicin Hydrochloride | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 14 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0069-4004 | DOXORUBICIN HYDROCHLORIDE INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 13 | Legacy NDC, 2 package rows | 20241113_00634b2b-4e48-4178-8877-28582af894ad.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0069-4004-05 | 00069400405 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-4004-05) > 5 mL in 1 VIAL, SINGLE-DOSE | 2013-03-17 | 0000-00-00 | No | No | Current |